LifeSci Capital initiated coverage of Immunome (IMNM) with an Outperform rating and $20 price target
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on IMNM:
Education
About Us
Working with TipRanks
Follow Us
